Bio-Rad Laboratories, Inc. (N:BIO)

Business Focus: Medical Equipment, Supplies & Distribution

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for BIO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 6th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 2/20 Jun 1/20 Crowley Michael Direct Ownership Bio-Rad A Common Stock S - Open market or private sale -1,500 $485.40
May 14/20 May 13/20 Hutton Ronald W Direct Ownership Bio-Rad A Common Stock S - Open market or private sale -443 $457.35
Apr 30/20 Apr 29/20 Last Andrew J. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -1,000  
Apr 30/20 Apr 29/20 Last Andrew J. Direct Ownership Bio-Rad A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -346 $436.27
Apr 30/20 Apr 29/20 Last Andrew J. Direct Ownership Bio-Rad A Common Stock M - Exercise or conversion exempt under rule 16b-3 1,000  
May 1/20 Apr 29/20 Ramalingam Ajit Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 1,384  
Apr 9/20 Apr 8/20 Daskal Ilan Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -700  
Apr 9/20 Apr 8/20 Daskal Ilan Direct Ownership Bio-Rad A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -243 $403.06
Apr 9/20 Apr 8/20 Daskal Ilan Direct Ownership Bio-Rad A Common Stock M - Exercise or conversion exempt under rule 16b-3 700  
Apr 1/20 Apr 1/20 Ramalingam Ajit Direct Ownership No securities are beneficially owned Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BIO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 6th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 2/20 Jun 1/20 Crowley Michael Direct Ownership Bio-Rad A Common Stock S - Open market or private sale -1,500 $485.40
May 14/20 May 13/20 Hutton Ronald W Direct Ownership Bio-Rad A Common Stock S - Open market or private sale -443 $457.35
May 1/20 Apr 29/20 Ramalingam Ajit Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 1,384  
Apr 30/20 Apr 29/20 Last Andrew J. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -1,000  
Apr 30/20 Apr 29/20 Last Andrew J. Direct Ownership Bio-Rad A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -346 $436.27
Apr 30/20 Apr 29/20 Last Andrew J. Direct Ownership Bio-Rad A Common Stock M - Exercise or conversion exempt under rule 16b-3 1,000  
Apr 9/20 Apr 8/20 Daskal Ilan Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -700  
Apr 9/20 Apr 8/20 Daskal Ilan Direct Ownership Bio-Rad A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -243 $403.06
Apr 9/20 Apr 8/20 Daskal Ilan Direct Ownership Bio-Rad A Common Stock M - Exercise or conversion exempt under rule 16b-3 700  
Apr 1/20 Apr 1/20 Ramalingam Ajit Direct Ownership No securities are beneficially owned Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $BIO

Competitors

Competitors with Recent Insider Filings
DexCom (OQ:DXCM)
Alpha Pro Tech, (A:APT)
Tandem Diabetes Care (OQ:TNDM)